<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou JX</submitter><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>50594-50607</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5584173</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(31)</volume><pubmed_abstract>Gene fusion is one of the hallmarks of cancer. Recent advances in RNA-seq of cancer transcriptomes have facilitated the discovery of fusion transcripts. In this study, we report identification of a surprisingly large number of fusion transcripts, including six &lt;i>KANSARL&lt;/i> (&lt;i>KANSL1&lt;/i>-&lt;i>ARL17A&lt;/i>) transcripts that resulted from the fusion between the &lt;i>KANSL1&lt;/i> and &lt;i>ARL17A&lt;/i> genes using a RNA splicingcode model. Five of these six &lt;i>KANSARL&lt;/i> fusion transcripts are novel. By systematic analysis of RNA-seq data of glioblastoma, prostate cancer, lung cancer, breast cancer, and lymphoma from different regions of the World, we have found that &lt;i>KANSARL&lt;/i> fusion transcripts were rarely detected in the tumors of individuals from Asia or Africa. In contrast, they exist in 30 - </pubmed_abstract><journal>Oncotarget</journal><pubmed_title>Identification of &lt;i>KANSARL&lt;/i> as the first cancer predisposition fusion gene specific to the population of European ancestry origin.</pubmed_title><pmcid>PMC5584173</pmcid><funding_grant_id>R01 HL131013</funding_grant_id><funding_grant_id>R21 ES027058</funding_grant_id><pubmed_authors>Zhou JX</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Ning S</pubmed_authors><pubmed_authors>Yuan F</pubmed_authors><pubmed_authors>Tang L</pubmed_authors><pubmed_authors>Zhuo DD</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Zhuo D</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of &lt;i>KANSARL&lt;/i> as the first cancer predisposition fusion gene specific to the population of European ancestry origin.</name><description>Gene fusion is one of the hallmarks of cancer. Recent advances in RNA-seq of cancer transcriptomes have facilitated the discovery of fusion transcripts. In this study, we report identification of a surprisingly large number of fusion transcripts, including six &lt;i>KANSARL&lt;/i> (&lt;i>KANSL1&lt;/i>-&lt;i>ARL17A&lt;/i>) transcripts that resulted from the fusion between the &lt;i>KANSL1&lt;/i> and &lt;i>ARL17A&lt;/i> genes using a RNA splicingcode model. Five of these six &lt;i>KANSARL&lt;/i> fusion transcripts are novel. By systematic analysis of RNA-seq data of glioblastoma, prostate cancer, lung cancer, breast cancer, and lymphoma from different regions of the World, we have found that &lt;i>KANSARL&lt;/i> fusion transcripts were rarely detected in the tumors of individuals from Asia or Africa. In contrast, they exist in 30 - </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-05-01T08:56:44.539Z</modification><creation>2019-03-27T02:55:24Z</creation></dates><accession>S-EPMC5584173</accession><cross_references><pubmed>28881586</pubmed><doi>10.18632/oncotarget.16385</doi></cross_references></HashMap>